Daunorubitec Benefits & Uses

Daunorubitec is used to treat the following -

Other Benefits

B-Cell Acute Lymphoblastic Leukemia

Daunorubitec Dosage & How to Take

This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.

Find the right dosage based on disease and age

Age Group	Dosage
Adult	Disease: Blood Cancer Before or After Meal: As advised by a physician Single Maximum Dose: 75 mg Dosage Route: Parenteral Frequency: 1 daily Course Duration: 6 days Special Instructions: Repeat every 3 to 4weeks
Geriatric	Disease: Blood Cancer Before or After Meal: As advised by a physician Single Maximum Dose: 50 mg Dosage Route: Parenteral Frequency: 1 daily Course Duration: 6 days Special Instructions: Repeat every 3 to 4weeks
13 - 18 years (Adolescent)	Disease: Blood Cancer Before or After Meal: As advised by a physician Single Maximum Dose: 50 mg Dosage Route: Parenteral Frequency: 1 Weekly Course Duration: 3 weeks Special Instructions: As prescribed by the doctor
2 - 12 years (Child)	Disease: Blood Cancer Before or After Meal: As advised by a physician Single Maximum Dose: 50 mg Dosage Route: Parenteral Frequency: 1 Weekly Course Duration: 3 weeks Special Instructions: As prescribed by the doctor
Infant (1 month to 2 years)	Disease: Blood Cancer Before or After Meal: As advised by a physician Single Maximum Dose: 1 mg/kg Dosage Route: Parenteral Frequency: 1 Weekly Course Duration: 3 weeks Special Instructions: As prescribed by the doctor

Daunorubitec Related Warnings

Is the use of Daunorubitec safe for pregnant women?

Daunorubitec shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.

Severe
Is the use of Daunorubitec safe during breastfeeding?

Daunorubitec may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.

Severe
What is the effect of Daunorubitec on the Kidneys?

Daunorubitec may cause harmful effects on kidney. if you feel its having any such effect, then stop taking this drug, and restart only on your doctor's advice.

Moderate
What is the effect of Daunorubitec on the Liver?

The liver can be affected by Daunorubitec. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Daunorubitec only after medical advice.

Moderate
What is the effect of Daunorubitec on the Heart?

The heart can be affected by Daunorubitec. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.

Moderate

Severe Interaction of Daunorubitec with Other Drugs

Daunorubitec should not be taken with following medicines due to severe side effects it may cause to patients -

Severe

Daunorubitec Contraindications

If you are suffering from any of the following diseases, you should not take Daunorubitec unless your doctor advises you to do so -

Kidney Disease
Liver Disease
Heart Disease
Thyroid problems
Potassium Deficiency
Herpes

Frequently asked Questions about Daunorubitec

Is this Daunorubitec habit forming or addictive?

Forming a habit of Daunorubitec has not been reported.

No
Is it safe to drive or operate heavy machinery when consuming?

After taking Daunorubitec, you should not drive or work on any heavy machine, as Daunorubitec can make you drowsy.

Dangerous
Is it safe?

Yes, Daunorubitec is safe but you must consult your doctor before taking it.

Safe, but take only on Doctor's advise
Is it able to treat mental disorders?

No, Daunorubitec cannot treat any kind of mental disorder.

No

Daunorubitec Interactions with Food and Alcohol

Interaction between Food and Daunorubitec

It is safe to take Daunorubitec with food.

Safe
Interaction between Alcohol and Daunorubitec

Taking alcohol with Daunorubitec can be dangerous.

Severe

See all substitutes for Daunorubitec

This medicine data has been created by -

Vikas Chauhan

B.Pharma, Pharmacy
5 Years of Experience

References

April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 405-406

KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 867

Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Daunorubicin (daunorubicin hydrochloride)

Daunorubitec Injection